Mereo BioPharma Group PLC (MREO)
2.785
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
2.785
0.00 (0.00%)
After-Hours: 18:40
Mereo BioPharma Group Price: 2.785 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 2.81 | 2.851 | 2.75 | 2.78 | 790447.0 |
| Apr 22, 2024 | 2.73 | 2.81 | 2.620 | 2.79 | 1.065M |
| Apr 19, 2024 | 2.62 | 2.668 | 2.53 | 2.64 | 912723.0 |
| Apr 18, 2024 | 2.56 | 2.675 | 2.525 | 2.65 | 814717.0 |
| Apr 17, 2024 | 2.70 | 2.71 | 2.58 | 2.58 | 601205.0 |
| Apr 16, 2024 | 2.68 | 2.70 | 2.61 | 2.69 | 591800.0 |
| Apr 15, 2024 | 2.68 | 2.720 | 2.605 | 2.67 | 1.251M |
| Apr 12, 2024 | 2.80 | 2.820 | 2.64 | 2.72 | 1.311M |
| Apr 11, 2024 | 2.96 | 2.997 | 2.72 | 2.74 | 1.651M |
| Apr 10, 2024 | 3.03 | 3.07 | 2.93 | 2.94 | 776215.0 |
| Apr 09, 2024 | 3.18 | 3.18 | 2.984 | 3.13 | 851304.0 |
| Apr 08, 2024 | 3.27 | 3.27 | 3.14 | 3.17 | 628091.0 |
| Apr 05, 2024 | 3.23 | 3.36 | 3.180 | 3.29 | 710458.0 |
| Apr 04, 2024 | 3.46 | 3.468 | 3.19 | 3.26 | 952020.0 |
| Apr 03, 2024 | 3.38 | 3.48 | 3.32 | 3.41 | 604605.0 |
| Apr 02, 2024 | 3.40 | 3.409 | 3.25 | 3.38 | 877297.0 |
| Apr 01, 2024 | 3.35 | 3.475 | 3.20 | 3.41 | 933227.0 |
| Mar 28, 2024 | 3.10 | 3.45 | 3.05 | 3.30 | 2.283M |
| Mar 27, 2024 | 3.00 | 3.09 | 2.920 | 3.00 | 451749.0 |
| Mar 26, 2024 | 2.98 | 3.10 | 2.915 | 2.95 | 990225.0 |
| Mar 25, 2024 | 2.98 | 3.005 | 2.86 | 2.97 | 1.311M |
| Mar 22, 2024 | 2.995 | 3.04 | 2.859 | 2.98 | 1.869M |
| Mar 21, 2024 | 3.08 | 3.11 | 2.96 | 2.96 | 1.021M |
| Mar 20, 2024 | 3.02 | 3.12 | 2.97 | 3.10 | 853161.0 |
| Mar 19, 2024 | 3.09 | 3.13 | 3.00 | 3.04 | 671002.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.33
Minimum
May 11 2022
6.500
Maximum
Apr 24 2019
2.145
Average
2.10
Median
Nov 22 2019
Price Benchmarks
| Adaptimmune Therapeutics PLC | 1.08 |
| Biodexa Pharmaceuticals Plc | 0.7405 |
| NuCana PLC | 3.84 |
| TC BioPharm (Holdings) PLC | 1.51 |
| Autolus Therapeutics PLC | 4.215 |
Price Related Metrics
| PS Ratio | 36.73 |
| Price to Book Value | 7.729 |
| Earnings Yield | -7.18% |
| Market Cap | 390.62M |